![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiOQJ03IwQctAfnu-8j1x_Jiv-uSCDhKTrTPIR0xFaa-NXE3JDo2UmzdkWTXbTtecVk8lGm9PmLnXVcwFkbThqQPxbkx5MxKAyvwXSHSZc7fCuzLw7wuZ5Lc2h0k5AUpEn9pPTOUZCp7h3-/s200/Biotech+updated+logo.jpg)
The 2011 Biotech/Life Science Conference features a diverse group of speakers and panel discussions on timely topics such as financing, personalized medicine and regulatory and reimbursement. Confirmed speakers include: Deirdre P. Connelly, President, North America Pharmaceuticals, GlaxoSmithKline; Robert Cascella, President and CEO, Hologic; David P. King, Chairman and CEO, LabCorp; David Mott, General Partner, NEA (former CEO of MedImmune) and Larry Stern, Chairman and CEO, Talecris Biotherapeutics.
Tweet: @CEDNC 2011 Biotech/Life Science Conference slated for Feb 21-22 in Raleigh NC -http://bit.ly/gFUf9y #entrepreneur #CEDNCLifeScienceCon
To register for the CED Biotech/Life Science Conference, visit http://bit.ly/gFUf9y
Speakers:
Deirdre Connelly
David King
David Mott
Lawrence D. Stern
Robert Cascella
No comments:
Post a Comment